Tag Archives: EC

European Pharma Bets on Greek Salvation

The French philosopher Pascal calculated that it was better to believe in God than to disbelieve. After offering the country a €2.88 billion cap on drug spending, it looks like European pharma is taking that view with regard to Greece. Reflector reports. The European pharma industry looks like it is accepting Pascal’s Wager in Greece. […]
Posted in Europe, Global, Guest Blog | Also tagged , , , , , | Leave a comment

EFPIA Calls for New Deal in Europe

EFPIA president Andrew Witty is hoping that the deepening European economic crisis will impel European leaders towards more courageous and radical solutions, writes Reflector. With the European economic and financial crisis deepening all the time, the healthcare sector in general — and the pharmaceutical sector in particular — faces further constraints from cost cutting. As […]
Posted in Europe, Guest Blog, healthcare, Op-Ed, Regulatory | Also tagged , , , , , | Leave a comment

Innovators: Take a Leaf from the Generic Industry Book

No-one can accuse the European generic industry of indolence. It supplies huge quantities of medicines to European healthcare suppliers — its volume is estimated at around a half of the market. It is accounting for a growing share of marketing authorization applications in Europe. And its industry association, the EGA, has turned it from being […]
Posted in Europe, healthcare, Regulatory | Also tagged , , , , , , , | Leave a comment

And What Exactly is a Stakeholder?

Pharma’s uncritical use of the word ‘stakeholder’ has increased to the point where it can refer to almost anyone connected to the industry. But this can have serious consequences, warns Reflector. Like it or not (and frankly, I don’t), stakeholders are here to stay in European pharmaceutical affairs. Don’t get me wrong. I’ve no objection […]
Posted in Europe, Global, Guest Blog, Regulatory | Also tagged , , , , , , , | 1 Comment
  • Categories

  • Meta